Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,694 | -89,024 | -71,584 | -37,662 | -51,384 |
| Depreciation Amortization | 36 | 741 | -4,306 | 215 | 254 |
| Accounts payable and accrued liabilities | 817 | 810 | -2,250 | 411 | 389 |
| Other Working Capital | -1,121 | -4,541 | 1,401 | 438 | 514 |
| Other Operating Activity | 33,661 | 18,822 | 15,470 | 4,521 | 3,456 |
| Operating Cash Flow | $-70,301 | $-73,192 | $-61,269 | $-32,077 | $-46,771 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -173,896 | -36,826 | -148,263 | 0 | -1,620 |
| PPE Investments | 55 | -44 | -149 | -612 | -12 |
| Other Investing Activity | 0 | 873 | 0 | 0 | 0 |
| Investing Cash Flow | $-173,841 | $-35,997 | $-148,412 | $-612 | $-1,632 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 47,000 |
| Common Stock Issued | 219,084 | 93,977 | 399 | 591 | 860 |
| Other Financing Activity | -217 | 39,188 | 233,887 | -2,390 | 1,241 |
| Financing Cash Flow | $218,867 | $133,165 | $234,286 | $-1,799 | $49,101 |
| Beginning Cash Position | 124,171 | 100,195 | 75,590 | 110,078 | 47,786 |
| End Cash Position | 98,896 | 124,171 | 100,195 | 75,590 | 48,484 |
| Net Cash Flow | $-25,275 | $23,976 | $24,605 | $-34,488 | $698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,301 | -73,192 | -61,269 | -32,077 | -46,771 |
| Capital Expenditure | -158 | -44 | -149 | -612 | -12 |
| Free Cash Flow | -70,459 | -73,236 | -61,418 | -32,689 | -46,783 |